| 2023年年报 | 2023年中报 | 2022年年报 | 2022年中报 | |
|---|---|---|---|---|
| 营业收入(元) | ||||
| 肠胃康(元) | 190,737,269.39 | 134,950,876.21 | 184,551,872.85 | 92,545,013.07 |
| 头孢制剂系列(元) | 385,012,879.24 | 224,594,230.37 | 407,462,887.39 | 206,887,961.49 |
| 医疗服务费(元) | 172,763,332.47 | 86,283,872.65 | 169,949,710.58 | 80,570,924.83 |
| 医疗器械(元) | 789,523.07 | 786,136.77 | 104,978,509.44 | 39,546,067.01 |
| 原料药及中间体(元) | 249,863,220.74 | 289,693,614.38 | 389,643,319.78 | 331,898,046.95 |
| 其他主营业务(元) | - | - | - | 303,646,807.34 |
| 其他收入(元) | - | 10,796,704.47 | 21,821,882.55 | 10,039,818.83 |
| 其他(元) | 456,770,716.75 | 212,469,136.21 | 500,644,010.59 | 303,646,807.34 |
| 营业成本(元) | ||||
| 肠胃康(元) | 37,843,625.99 | 25,576,994.05 | 38,252,543.21 | 19,428,099.72 |
| 头孢制剂系列(元) | 135,363,190.20 | 73,354,419.28 | 128,339,393.39 | 57,808,107.57 |
| 医疗服务费(元) | 147,297,032.12 | - | 145,512,550.55 | - |
| 医疗器械(元) | 794,774.97 | - | 33,199,958.84 | - |
| 原料药及中间体(元) | 245,072,281.53 | 270,507,001.75 | 336,887,124.18 | 287,489,023.35 |
| 其他主营业务(元) | - | - | - | 179,088,098.48 |
| 其他收入(元) | - | 2,731,393.27 | 7,677,104.68 | 4,183,877.74 |
| 其他(元) | 334,521,367.25 | 147,087,992.09 | 320,955,101.35 | 179,088,098.48 |
| 毛利(元) | ||||
| 肠胃康(元) | 152,893,643.40 | 109,373,882.16 | 146,299,329.64 | 73,116,913.35 |
| 头孢制剂系列(元) | 249,649,689.04 | 151,239,811.09 | 279,123,494.00 | 149,079,853.92 |
| 医疗服务费(元) | 25,466,300.35 | - | 24,437,160.03 | - |
| 医疗器械(元) | -5,251.90 | - | 71,778,550.60 | - |
| 原料药及中间体(元) | 4,790,939.21 | 19,186,612.63 | 52,756,195.60 | 44,409,023.60 |
| 其他主营业务(元) | - | - | - | 124,558,708.86 |
| 其他收入(元) | - | 8,065,311.20 | 14,144,777.87 | 5,855,941.09 |
| 其他(元) | 122,249,349.50 | 65,381,144.12 | 179,688,909.24 | 124,558,708.86 |
| 毛利率(%) | ||||
| 肠胃康(%) | 80.16 | 81.05 | 79.27 | 79.01 |
| 头孢制剂系列(%) | 64.84 | 67.34 | 68.50 | 72.06 |
| 医疗服务费(%) | 14.74 | - | 14.38 | - |
| 医疗器械(%) | -0.67 | - | 68.37 | - |
| 原料药及中间体(%) | 1.92 | 6.62 | 13.54 | 13.38 |
| 其他主营业务(%) | - | - | - | 41.02 |
| 其他收入(%) | - | 74.70 | 64.82 | 58.33 |
| 其他(%) | 26.76 | 30.77 | 35.89 | 41.02 |
| 收入构成(%) | ||||
| 肠胃康(%) | 13.10 | 14.06 | 10.37 | 6.76 |
| 头孢制剂系列(%) | 26.44 | 23.41 | 22.90 | 15.11 |
| 医疗服务费(%) | 11.87 | 8.99 | 9.55 | 5.89 |
| 医疗器械(%) | 0.05 | 0.08 | 5.90 | 2.89 |
| 原料药及中间体(%) | 17.16 | 30.19 | 21.90 | 24.25 |
| 其他主营业务(%) | - | - | - | 22.18 |
| 其他收入(%) | - | 1.13 | 1.23 | 0.73 |
| 其他(%) | 31.37 | 22.14 | 28.14 | 22.18 |
| 毛利构成(%) | ||||
| 肠胃康(%) | 27.55 | 30.96 | 19.04 | 14.02 |
| 头孢制剂系列(%) | 44.98 | 42.81 | 36.33 | 28.58 |
| 医疗服务费(%) | 4.59 | 0.00 | 3.18 | 0.00 |
| 医疗器械(%) | 0.00 | 0.00 | 9.34 | 0.00 |
| 原料药及中间体(%) | 0.86 | 5.43 | 6.87 | 8.51 |
| 其他主营业务(%) | - | - | - | 23.88 |
| 其他收入(%) | - | 2.28 | 1.84 | 1.12 |
| 其他(%) | 22.03 | 18.51 | 23.39 | 23.88 |